Dr. Oz’s online health site seeks addiction expert, Dr. Cidambi’s views on Probuphine, which was recently approved by the FDA. Probuphine is intended for treatment for opioid dependence and it is used to treat individuals suffering from opiate withdrawal and opiate cravings. Dr. Cidambi, Center for Network Therapy’s medical director argues why Probuphine will flop.

Insurance

In-network with:
Aetna
AmeriHealth
Anthem BCBS
Beacon Health Options
Emblem BCBS
GHI
Empire BCBS
Horizon BCBS (EPO, HMO, PPO)
Oscar
QualCare
United Health/Optum/Oxford
Emblem GHI*
Humana*

 

* If the QualCare logo is on the
insurance card

Follow Us @Instagram